Polaris Market Research presents its latest market research report, titled AI in Genomics Market. It is a comprehensive market research report analyzing the fast-evolving AI in Genomics market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study is a combination of qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the AI in Genomics market and its outlook during the forecast period.

AI in Genomics Market Key Takeaways

• The AI in genomics market size was valued at USD 1.04 billion in 2025.
• The market is estimated to reach USD 21.08 billion by 2034.
• The market is projected to witness a CAGR of 39.74% from 2026 to 2034.
• The Software segment held 50.0% of the market share in 2025.
• The Population Genomics application segment is likely to grow at a 40.8% CAGR during the forecast period.
• The North America region held 43.0% of market share in 2025.
• The Asia Pacific region is expected to grow at a 41.5% CAGR from 2026 to 2034.

What is AI in Genomics Market?

AI in genomics refers to the application of artificial intelligence technologies in the analysis, interpretation, and management of genomic data. The technology helps researchers and healthcare providers identify genetic variations, predict disease risks, accelerate drug discovery, and improve precision medicine outcomes by processing genomic datasets through machine learning algorithms and cloud-based analytical platforms worldwide.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/ai-in-genomics-market

Market Dynamics

The report examines the key market dynamics influencing the growth and development of the AI in Genomics market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.

Key Market Driver: Precision Medicine Expansion

Precision medicine is increasing the demand for advanced genomic analysis tools across healthcare and research institutions. AI solutions are used by healthcare providers for disease risk assessment, formulation of personalized treatment strategies, and patient health outcomes improvement. Increasing acceptance of genetic testing and therapies based on biomarkers is creating significant amounts of genomic data that need advanced AI-driven analytics, thereby driving market growth.

Market Opportunity: Regenerative Medicine and Multi-Omics Research

Rising adoption of regenerative medicine, precision medicine, and use of organoids in research activities is opening up more business opportunities for market players. Advanced applications of artificial intelligence are enabling scientists to discover genetic targets and develop more accurate predictions about treatment outcomes. Commercialization of organoids and increasing multi-omics research are expected to generate substantial demand for genomics platforms in the coming years.

Emerging Market Trend: Genomic Data Expansion Supporting AI Adoption

The increasing genomic sequencing activity is contributing greatly to the rise in demand for AI-enabled data analytics systems, as research labs and healthcare centers accumulate large volumes of genomic data requiring advanced processing. With the assistance of AI technology, the process of analysis gets faster while it becomes easier to discover genetic patterns and disease biomarkers, reflecting a broader shift toward AI-driven genomics research initiatives.

Market Challenge: Data Privacy and Security Concerns

Privacy issues and compliance requirements continue to hinder market development, as genomics includes highly personal patient information that must be stored and processed through secure systems. Differences in regulation systems between countries add extra challenges for technology vendors, while high costs of integration and a shortage of qualified specialists further limit the pace of genomics AI adoption among smaller organizations.

How Is Market Segmentation Done?

The research gives an in-depth segmental analysis of the AI in genomics industry. The segmentation in the market has been done on the basis of offering, which includes software, services, and cloud platforms; application, which includes variant interpretation, population genomics, drug target discovery, clinical diagnostics, and precision medicine; and end user, which includes research institutes, hospitals, biopharmaceutical companies, and diagnostic laboratories.

Which Region Leads Market Demand?

The report includes a regional analysis of the AI in genomics market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market dominates the overall market, attributed to the presence of advanced healthcare facilities, adoption of genomic technologies, and strong research funding, with the U.S. as the largest contributor. Further, the Asia Pacific market is expected to witness significant growth during the forecast period, influenced by growing genomics investments and expanding healthcare infrastructure across China, Japan, India, and South Korea.

Who Are the Key Market Players?

The report presents a detailed competitive analysis of the AI in Genomics industry. Player positioning and their strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, technological developments, etc., have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.

A few of the key players in the market include:

DNAnexus, Inc., Fabric Genomics, Inc., Google DeepMind, IBM Corporation, Illumina, Inc., Microsoft Corporation, NVIDIA Corporation, Oracle Corporation, SAP SE, SOPHiA GENETICS SA, Tempus AI, Inc., Thermo Fisher Scientific Inc..

Future Outlook

The AI in genomics market is projected to grow and evolve until the forecast year 2034 as demand grows, applications widen, and industry players respond to changing needs. Increasing demand from customers for technology that provides clinical impact, scalability, and strong data security is driving development. Long-term growth opportunities are expected to emerge from regenerative medicine, organoid commercialization, multi-omics research, and AI-assisted drug discovery, enabling stakeholders to understand opportunities likely to shape the market during the forecast period.

More Trending Latest Reports By Polaris Market Research:

leading-top-10-companies-in-drone-batteries-market-to-know-in-2025

methanol-market

global-gypsum-board-market

global-soda-ash-market

distributed-antenna-system-das-market

esg-advisory-market

athletic-footwear-market

adhesives-sealants-market

insurtech-market